Menu
Back to Journals » OncoTargets and Therapy » Volume 16
Review
Evaluating Elacestrant in the Management of ER-Positive, HER2-Negative Advanced Breast Cancer: Evidence to Date
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 9,003 | Dovepress* | 4,408+ | 121 | 4,529 | |
| PubMed Central* | 4,595 | 500 | 5,095 | ||
| Totals | 9,003 | 621 | 9,624 | ||
| *Since 23 March 2023 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 12 | 0 | 0 | 0 | 4 | 8 |
View citations on PubMed Central and Google Scholar